Generali

Model update: NatCat hits Generali

29/11/23 -"We have cut our Generali Target Price due to the weaker H2 which was impacted by higher NatCat losses than had been forecast in our previous model. Despite maintaining a cautious outlook, we ..."

PDF page sample
Pages
62
Language
English
Published on
29/11/23
Download
You may also be interested by these reports :
08/05/25
Scor reported strong results in both P&C and Life & Health, despite slightly weaker-than-expected top-line growth. The P&C segment delivered high ...
08/05/25
We have updated our model to reflect Scor’s 1Q25 results and revised our assumptions for FY25 and beyond. The results were well ahead of expectations ...
07/05/25
Storebrand’s 1Q25 results came in slightly below expectations, mainly due to softer performance in the insurance segment. However, part of the ...
07/05/25
AXA reported 1Q 25 activity indicators broadly in line with expectations, reflecting robust top-line growth, in line with recent trends. The Solvency ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO